Medipost Acquires Additional 920,000 Shares of Medipost CDMO Stock
[Asia Economy Reporter Kang Nahum] Medipost announced on the 22nd that it will additionally acquire 920,000 shares of its subsidiary Medipost CDMO for 46 billion KRW.
After the acquisition, Medipost's stake in Medipost CDMO will become 100%. The scheduled date for the stock acquisition is the 1st of next month.
Hot Picks Today
"Stocks Are Not Taxed, but Annual Crypto Gains Over 2.5 Million Won to Be Taxed Next Year... Investors Push Back"
- "Contracts Signed Without Viewing at 1.6 Billion Won"... Jamsil and Seongbuk Jeonse Prices Jump 200 Million Won in a Month [Real Estate AtoZ]
- [Breaking] Blue House expresses "deep regret over Samsung negotiation breakdown... urges both sides to do their best for a final agreement"
- "Don't Throw Away Coffee Grounds" Transformed into 'High-Grade Fuel' in Just 90 Seconds [Reading Science]
- "Even With a 90 Million Won Salary and Bonuses, It Doesn’t Feel Like Much"... A Latecomer Rookie Who Beat 70 to 1 Odds [Scientists Are Disappearing] ③
Medipost stated the purpose of the acquisition as "entry into the North American cell and gene therapy CDMO business."
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
